EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Understanding paralogous epilepsy–associated GABA A receptor variants: Clinical implications, mechanisms, and potential pitfalls

Anthony S H Kan iD, Ali S Kusay, Nazanin A Mohammadi, Susan X N Lin, Vivian W Y Liao, Gaetan Lesca, Sabrine Souci, Mathieu Milh, Palle Christophersen, Mary Chebib, Rikke S Møller, Nathan L Absalom und 2 weitere

Proceedings of the National Academy of Sciences · 2024

DOI: 10.1073/pnas.2413011121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Anthony S H Kan und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Sciences, Faculty of Medicine and Health, Brain and Mind Centre, The University of Sydney, Sydney, NSW 2006, Australia. Hauptthemen laut MEDLINE: Receptors, GABA-A, Epilepsy. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DHAC | National Health and Medical Research Council (NHMRC), Novo Nordisk Fonden (NNF), Lundbeck Foundation (Lundbeckfonden).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent discoveries have revealed that genetic variants in γ-aminobutyric acid type A (GABA A ) receptor subunits can lead to both gain-of-function (GOF) and loss-of-function (LOF) receptors. GABA A receptors, however, have a pseudosymmetrical pentameric assembly, and curiously diverse functional outcomes have been reported for certain homologous variants in paralogous genes (paralogous variants). To investigate this, we assembled a cohort of 11 individuals harboring paralogous M1 proline missense variants in GABRA1 , GABRB2 , GABRB3, and GABRG2. Seven mutations (α1 P260L , α1 P260S , β2 P252L , β3 P253L , β3 P253S , γ2 P282A , and γ2 P282S ) in α1β2/3γ2 receptors were analyzed using electrophysiological examinations and molecular dynamics simulations. All individuals in the cohort were diagnosed with developmental and epileptic encephalopathy, with a median seizure onset age of 3.5 mo, and all exhibited global developmental delay. The clinical data for this cohort aligned with established GABA A receptor GOF but not LOF cohorts. Electrophysiological assessments revealed that all variants caused GOF by increasing GABA sensitivity by 3- to 23-fold. In some cases, this was accompanied by LOF traits such as reduced maximal current amplitude and enhanced receptor desensitization. The specific subunit mutated and whether the mutation occurred in one or two subunits within the pentamer influenced the overall effects. Molecular dynamics simulations confirmed similar structural changes from all mutations, but with position-dependent asymmetry. These findings establish that paralogous variants affecting the 100% conserved proline residue in the M1 transmembrane helix of GABA A R subunits all lead to overall GOF traits. The unexpected asymmetric and mixed effects on receptor function have broader implications for interpreting functional analyses for multimeric ion-channel proteins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, GABA-AEpilepsyHumansFemaleMaleMutation, MissenseMolecular Dynamics SimulationChildInfantChild, PreschoolGain of Function MutationProtein Subunits

Stichwörter der Autor:innen

GABRA1GABRB3GABRG2epilepsyneurodevelopmental disorders

Substanzen

Receptors, GABA-AGABRB3 protein, humanGABRA1 protein, humanGABRB2 protein, humanGABRG2 protein, humanProtein Subunits

Autor:innen und Institutionen

  • School of Medical Sciences, Faculty of Medicine and Health, Brain and Mind Centre, The University of Sydney, Sydney, NSW 2006, Australia.
  • Department of Biomedical and Clinical Sciences, Linköping University, Linköping SE-581 83, Sweden.
  • Department of Epilepsy Genetics and Personalized Treatment, Danish Epilepsy Center Filadelfia, Member of the European Reference Network EpiCARE, Dianalund DK-4293, Denmark.
  • Department of Regional Health Research, University of Southern Denmark, Odense DK-5230, Denmark.
  • Department of Medical Genetics, Member of the European Reference Network EpiCARE, Hospices Civils de Lyon, Lyon 69002, France.
  • Institut Neuromyogène, CNRS UMR 5310-INSERM U1217, Université de Lyon, Université Claude Bernard Lyon 1, Lyon 69008, France.

ORCID-Profile: Anthony S H Kan, Anders A Jensen, Philip K Ahring

Förderung

  • DHAC | National Health and Medical Research Council (NHMRC)
  • Novo Nordisk Fonden (NNF)
  • Lundbeck Foundation (Lundbeckfonden)

Zitieren

APA

Kan, A. S. H., Kusay, A. S., Mohammadi, N. A., Lin, S. X. N., Liao, V. W. Y., Lesca, G., Souci, S., Milh, M., Christophersen, P., Chebib, M., Møller, R. S., Absalom, N. L., Jensen, A. A., & Ahring, P. K. (2024). Understanding paralogous epilepsy–associated GABA A receptor variants: Clinical implications, mechanisms, and potential pitfalls. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2413011121

Vancouver

Kan ASH, Kusay AS, Mohammadi NA, Lin SXN, Liao VWY, Lesca G, et al. Understanding paralogous epilepsy–associated GABA A receptor variants: Clinical implications, mechanisms, and potential pitfalls. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2413011121

BibTeX
@article{Kan2024,
  author = {Kan, Anthony S H and Kusay, Ali S and Mohammadi, Nazanin A and Lin, Susan X N and Liao, Vivian W Y and Lesca, Gaetan and Souci, Sabrine and Milh, Mathieu and Christophersen, Palle and Chebib, Mary and Møller, Rikke S and Absalom, Nathan L and Jensen, Anders A and Ahring, Philip K},
  title = {Understanding paralogous epilepsy–associated GABA A receptor variants: Clinical implications, mechanisms, and potential pitfalls},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  doi = {10.1073/pnas.2413011121}
}
Kostenlos starten →